Cargando…

Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase

Prostate cancer is initially regulated by the androgen receptor (AR), a ligand-activated, transcription factor, and is in a hormone-dependent state (hormone-sensitive prostate cancer (HSPC)), but eventually becomes androgen-refractory (castration-resistant prostate cancer (CRPC)) because of mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jathal, Maitreyee K., Siddiqui, Salma, Vasilatis, Demitria M., Durbin Johnson, Blythe P., Drake, Christiana, Mooso, Benjamin A., D’Abronzo, Leandro S., Batra, Neelu, Mudryj, Maria, Ghosh, Paramita M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407237/ https://www.ncbi.nlm.nih.gov/pubmed/37380074 http://dx.doi.org/10.1016/j.jbc.2023.104973

Ejemplares similares

Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer
por: Steele, Thomas M., et al.
Publicado: (2023)

Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase
por: Jathal, Maitreyee K., et al.
Publicado: (2019)

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1
por: Hutcheson, Iain R, et al.
Publicado: (2011)

Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins
por: Hutcheson, IR, et al.
Publicado: (2010)

Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer
por: Mitsui, Keigo, et al.
Publicado: (2014)

Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling
por: Zhang, Y, et al.
Publicado: (2005)

Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin
por: Yoo, J-Y, et al.
Publicado: (2000)

ErbB3 Ligand Heregulin1 Is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation()()
por: Ma, Shiqi, et al.
Publicado: (2019)

Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies
por: Lucchesi, Christopher A., et al.
Publicado: (2023)

The Androgen Receptor is a negative regulator of eIF4E Phosphorylation at S209: Implications for the use of mTOR inhibitors in advanced prostate cancer
por: D’Abronzo, Leandro S., et al.
Publicado: (2017)

FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion
por: Benlimame, Naciba, et al.
Publicado: (2005)

The Role of ErbB Receptors in Infection
por: Ho, Jemima, et al.
Publicado: (2017)

eIF4E Phosphorylation in Prostate Cancer()()
por: D'Abronzo, Leandro S., et al.
Publicado: (2018)

Spinal nerve injury causes upregulation of ErbB2 and ErbB3 receptors in rat dorsal root ganglia
por: Mizobuchi, Satoshi, et al.
Publicado: (2013)

Targeting of erbB3 receptor to overcome resistance in cancer treatment
por: Ma, Jian, et al.
Publicado: (2014)

Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells
por: Katleba, Kimberley D., et al.
Publicado: (2023)

The interactome of human EGF/ErbB receptors
por: Uetz, Peter, et al.
Publicado: (2006)

Targeting ErbB3 Receptor in Cancer with Inhibitory Antibodies from Llama
por: Eliseev, Igor E., et al.
Publicado: (2021)

Nucleolar localization of the ErbB3 receptor as a new target in glioblastoma
por: Tagliaferro, Marzia, et al.
Publicado: (2022)

Corrigendum to “ErbB3 ligand, Heregulin1, is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation” [Neoplasia 21 (2019) 343–352]
por: Ma, Shiqi, et al.
Publicado: (2021)

Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK
por: Yao, Yong-Liang, et al.
Publicado: (2013)

Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
por: Sutherland, Robert L
Publicado: (2011)

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
por: Alvarado, Diego, et al.
Publicado: (2017)

Phosphotyrosine interactome of the ErbB-receptor kinase family
por: Schulze, Waltraud X, et al.
Publicado: (2005)

The ErbB receptor tyrosine kinases and their roles in cancer
por: Hynes, NE
Publicado: (2003)

Betacellulin-Induced Beta Cell Proliferation and Regeneration Is Mediated by Activation of ErbB-1 and ErbB-2 Receptors
por: Oh, Yoon Sin, et al.
Publicado: (2011)

Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants
por: Vasilatis, Demitria M., et al.
Publicado: (2023)

Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression
por: Ciardiello, Chiara, et al.
Publicado: (2016)

Melatonin upregulates ErbB1 and ErbB4, two primary implantation receptors, in pre-implantation mouse embryos
por: Moshkdanian, Ghazaleh, et al.
Publicado: (2017)

Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer
por: Roepstorff, Kirstine, et al.
Publicado: (2008)

Identification of Nucleolin as New ErbB Receptors- Interacting Protein
por: Di Segni, Ayelet, et al.
Publicado: (2008)

Negative regulation of ErbB family receptor tyrosine kinases
por: Sweeney, C, et al.
Publicado: (2004)

Structure-Function Analysis of Nucleolin and ErbB Receptors Interactions
por: Farin, Keren, et al.
Publicado: (2009)

Role of ErbB Receptors in Cancer Cell Migration and Invasion
por: Appert-Collin, Aline, et al.
Publicado: (2015)

Estrogen receptor transcription and transactivation: ErbB family of receptors in breast cancer
por: Hynes, NE, et al.
Publicado: (2001)

ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
por: Moghbeli, Meysam, et al.
Publicado: (2019)

DMBA promotes ErbB2-mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability
por: Ma, Zhikun, et al.
Publicado: (2018)

Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014)

Peptide G-Protein-Coupled Receptors and ErbB Receptor Tyrosine Kinases in Cancer
por: Moody, Terry W., et al.
Publicado: (2023)

Expression and Localization of Neuregulin-1 (Nrg1) and ErbB2/ErbB4 Receptors in Main Endocrine Organs of the Rhesus Monkey
por: Zhao, Wei-jiang
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7o0j4pmudreibgrtmdsqjur201